Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Doximity Releases 2026 Report on Physician AI Adoption Across 15 Medical Specialties

    19. März 2026

    Welldoc Bridges the Insulin Dosing Gap with New Real-World Evidence

    18. März 2026

    MedArrive Acquires Inbound Health Assets, Names Ophir Lotan CEO to Scale Hospital-at-Home Logistics

    18. März 2026
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»Health»MedArrive Acquires Inbound Health Assets, Names Ophir Lotan CEO to Scale Hospital-at-Home Logistics
    Health

    MedArrive Acquires Inbound Health Assets, Names Ophir Lotan CEO to Scale Hospital-at-Home Logistics

    HealthradarBy Healthradar18. März 2026Keine Kommentare2 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    MedArrive Acquires Inbound Health Assets, Names Ophir Lotan CEO to Scale Hospital-at-Home Logistics
    Share
    Facebook Twitter LinkedIn Pinterest Email


    MedArrive Acquires Inbound Health Assets, Names Ophir Lotan CEO to Scale Hospital-at-Home Logistics

    What You Should Know

    • The Acquisition: MedArrive, a technology platform that optimizes in-home care logistics, has acquired assets from Inbound Health. Financial details of the acquisition were not disclosed. 
    • The Tech Acquired: The acquisition specifically brings Inbound Health’s AI-backed patient-navigation capabilities into the MedArrive ecosystem. This technology uses AI scoring models to analyze clinical data and identify exactly when a patient is ready to transition from a hospital bed to a home-care setting.
    • The Leadership Change: MedArrive has appointed Ophir Lotan as its new CEO. Lotan is a veteran of healthcare tech scaling, having previously served as Chief Product Officer at Alto Pharmacy and as a founding team member at telehealth giant TytoCare.
    • The Market Problem: While the industry is desperate to shift care to the home (to reduce costs and hospital strain), the operational logistics are a nightmare. Most existing software either helps hospitals identify eligible patients or helps home-health agencies route their nurses—but rarely both.
    • The Solution: By combining MedArrive’s existing workforce routing logistics (scheduling clinicians to drive to homes) with Inbound’s AI patient-scoring (identifying which patients need to go home), the company is attempting to build the elusive end-to-end operational chassis for the hospital-at-home movement.

    Bridging the Gap Between Discharge and the Doorstep

    The “Hospital-at-Home” movement is the most universally agreed-upon trend in modern healthcare strategy. Everyone—from payers to health system CFOs to the patients themselves—wants to transition acute care out of expensive, overcrowded hospital wards and into the patient’s living room.

    Currently, health systems often use one set of tools (or manual workflows) to figure out who can go home. Meanwhile, home-health agencies use entirely different routing software to figure out how to get a nurse to that patient’s house.

    MedArrive built its reputation on the latter: workforce logistics. Their platform excels at managing clinician schedules, optimizing driving routes, and balancing capacity. By acquiring Inbound Health’s assets, MedArrive is moving upstream into the hospital itself.

    Inbound Health’s technology brings AI-powered patient scoring models trained across multiple hospital systems. It analyzes clinical data to identify patients who are ready to transition from acute care to home-based services, acting as an intelligent decision-support tool for discharge planners.



    Source link

    acquires assets CEO Health Healthcare Mergers & Acquisitions HospitalatHome Inbound Logistics Lotan MedArrive Names Ophir scale
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleMiniMed gets FDA nod for smaller insulin pump
    Next Article Welldoc Bridges the Insulin Dosing Gap with New Real-World Evidence
    ekass777x
    Healthradar
    • Website

    Related Posts

    Gadgets

    ChatGPT did not cure a dog’s cancer

    18. März 2026
    Health

    FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

    18. März 2026
    News

    PFA startup Field Medical appoints Mark Turco as CEO

    18. März 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202589 Views

    Nanoleaf LED face mask review: fantastic value for money, but only by cutting some corners

    16. Oktober 202569 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202537 Views

    Dexcom raises sales expectations, discusses G8 plans

    31. Juli 202530 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202589 Views

    Nanoleaf LED face mask review: fantastic value for money, but only by cutting some corners

    16. Oktober 202569 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.